eFFECTOR Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
eFFECTOR Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2019 to Q4 2023.
  • eFFECTOR Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $9.82M, a 10.8% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $9.82M +$957K +10.8% Dec 31, 2023 10-K 2024-03-26
Q4 2022 $8.86M +$625K +7.59% Dec 31, 2022 10-K 2024-03-26
Q4 2021 $8.24M +$612K +8.03% Dec 31, 2021 10-K 2024-03-26
Q2 2021 $0 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $0 Mar 31, 2021 10-Q 2021-06-03
Q4 2020 $7.62M +$555K +7.85% Dec 31, 2020 10-K 2023-03-08
Q4 2019 $7.07M Dec 31, 2019 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.